The oral Janus kinase inhibitor upadacitinib was well tolerated for moderate to severe inflammatory bowel disease over a ...

Celltrion, Inc. today announced that seven abstracts will be presented at the 2026 Digestive Disease Week® (DDW) Annual Meeting, taking place May 2-5 in Chicago, Illinois. The oral and poster ...

This case report describes a woman in her 60s diagnosed with primary vitreoretinal lymphoma (PVRL) with leptomeningeal ...

Buzzwords like "sculpt," "detox" and "boost your wellness" are commonly heard at trendy health spaces that offer lymphatic massages. In these wellness communities, there's an underlying sentiment that ...

The lymphatic system is part of the human immune system. It’s a collection of tissues and vessels that move a fluid called lymph throughout the body. A lymphatic drainage massage involves gently ...

Diagnosis hinges on excisional lymph node biopsy demonstrating Reed–Sternberg cells with mixed inflammatory infiltrate, followed by CT/PET staging; labs and infrequent marrow biopsy assess systemic ...

Debi Weiss was annoyed but not concerned when she started feeling weak and out of breath in January 2024. She thought it was a case of the flu. As the weeks passed, the Pilates instructor's symptoms ...

Follicular lymphoma, a common and usually slow-growing type of non-Hodgkin lymphoma (NHL), has long been deemed incurable: Though the disease responds well to initial treatment, oncologists tell ...

Jana Batson was just 31 years old and had a 1-year-old daughter when she was diagnosed with nodular sclerosing Hodgkin lymphoma, a type of cancer that affects the lymph system, which helps the body ...

For some people with ulcerative colitis (UC), the symptoms are mild. But for others, symptoms can quickly turn into a medical emergency called fulminant colitis. Fulminant colitis is rare, affecting ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

STOCKHOLM — Patients with moderately to severely active ulcerative colitis (UC) treated with the investigational, once-daily, oral obefazimod (Abivax, France) reported clinically meaningful ...